Michael J. Purcell International Money Express, Inc. (IMXI) insider trading activity

Michael J. Purcell is Director of International Money Express, Inc.. Currently has a direct ownership of 65,919 shares of IMXI, which is worth approximately $899,794. The most recent transaction as insider was on Jan 01, 2025, when has been sold 750 shares (Common Stock) at a price of $20.83 per share, resulting in proceeds of $15,622. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.9K

1.15% 3M change

20.31% 12M change

Total Value Held $899,794

Michael J. Purcell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2025	BUY Grant, award, or other acquisition	$15,622 $20.83 p/Share	750 Added 1.12%	65,919 Common Stock
Oct 01 2024	BUY Grant, award, or other acquisition	$15,619 $17.57 p/Share	889 Added 1.35%	65,169 Common Stock
Jul 25 2024	BUY Grant, award, or other acquisition	$5,000 $21.01 p/Share	238 Added 0.37%	64,280 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	$15,628 $20.27 p/Share	771 Added 1.19%	64,042 Common Stock
Jun 24 2024	BUY Grant, award, or other acquisition	$145,012 $20.43 p/Share	7,098 Added 10.09%	63,271 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	-	1,384 Added 2.4%	56,173 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	707 Added 1.27%	54,789 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	-	923 Added 1.68%	54,082 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	739 Added 1.37%	53,159 Common Stock
Jun 23 2023	BUY Grant, award, or other acquisition	-	5,919 Added 10.15%	52,420 Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	-	703 Added 1.49%	46,501 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	744 Added 1.6%	45,798 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	796 Added 1.74%	45,054 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	1,861 Added 4.04%	44,258 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	684 Added 1.59%	42,397 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	-	4,886 Added 10.49%	41,713 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	-	679 Added 1.81%	36,827 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	-	752 Added 2.04%	36,148 Common Stock
Nov 18 2021	BUY Open market or private purchase	$105,490 $15.07 p/Share	7,000 Added 16.51%	35,396 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	719 Added 2.47%	28,396 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	-	7,281 Added 20.83%	27,677 Common Stock
Apr 06 2021	BUY Grant, award, or other acquisition	-	799 Added 3.77%	20,396 Common Stock
Jan 07 2021	BUY Grant, award, or other acquisition	-	773 Added 3.79%	19,597 Common Stock
Oct 29 2020	BUY Grant, award, or other acquisition	-	1,521 Added 7.48%	18,824 Common Stock

Also insider at

TRHC

Tabula Rasa HealthCare, Inc. Healthcare

HEPA

Hepion Pharmaceuticals, Inc. Healthcare

Director

MJP